Brenton Coger, MD
Neurological Surgery · Springfield, MONPI 1427107283
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,054 of the $13,996 with a category attached, or 64.7%. 13 manufacturers reported payments, led by Globus Medical at 28.8% of the total. Reporting peaked in 2019 at $4,702 and has fallen 65.2% since, to $1,636 in 2025.
Across 96 payments — averaging $145.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$4K
- Aesculap, Inc.$4K
- Alphatec Spine, Inc$2K
- Medtronic$2K
- Stryker$1K
- Surgalign Spine Technologies, Inc.$558
- plus $860 from 7 others
What the payments were for
- Consulting fees$5584%
- Travel & lodging$9,05465%
- Food & beverage$4,38431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 26 | $4,038 |
| Aesculap, Inc. | 26 | $3,752 |
| Alphatec Spine, Inc | 12 | $1,696 |
| Medtronic(2 entities) | 13 | $1,693 |
| Stryker | 5 | $1,400 |
| Surgalign Spine Technologies, Inc. | 1 | $558 |
| Microvention, Inc. | 3 | $303 |
| Johnson & Johnson | 4 | $263 |
| KCI USA, Inc. | 2 | $174 |
| Bioventus LLC | 1 | $42 |
| Biotronik Inc. | 1 | $33 |
| Cerapedics Inc. | 1 | $28 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CREO$2,554
- YASARGIL ANEURYSM CLIPS$2,059
- SURPASS EVOLVE$1,313
- XABO$1,051
- PIVOX Oblique Lateral Spinal System$744
- FORTILINK-C IBF SYSTEM$558
- Other - Miscellaneous$547
- MULTIPLE$470
- MAZOR X SYSTEM$332
- WEB Aneurysm Embolization System$282
- RISE$224
- IdentiTi$150
- KODIAK$134
- UNID_PASS$132
- TRUFILL$126
- MAGNIFY SA$125
- ALTERA$123
- Direct Look Lat$123
- Mazor X Stealth Edition$106
- Spine$100
How this compares
$13,996 in reported general payments places this provider in the 75th percentile of 172 neurological surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 72 | $673 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 76 | $631 |
| Gabapentin | 56 | $497 |
| Oxycodone Hcl | 23 | $153 |
| Cyclobenzaprine Hcl | 12 | $45 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Springfield
- Alan ScarrowSpringfield$55K
- Mayur JayaraoSpringfield$31K
- Neill WrightSaint Louis$1.1M
- Wilson RaySaint Louis$586K
- Carlos BagleyKansas City$532K
- Kaywan GamadiaCape Girardeau$458K
- Camilo MolinaSaint Louis$412K
- Paul SantiagoSaint Louis$368K
- Daniel ScodarySaint Louis$278K
- Daniel HafezSaint Louis$273K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.